{"id":"https://openalex.org/W2275454249","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.7073","title":"Randomized phase II trial comparing every-3-week carboplatin/paclitaxel (C/P) versus every-3-week C with weekly P in advanced non-small cell lung cancer (NSCLC)","display_name":"Randomized phase II trial comparing every-3-week carboplatin/paclitaxel (C/P) versus every-3-week C with weekly P in advanced non-small cell lung cancer (NSCLC)","publication_year":2004,"publication_date":"2004-07-15","ids":{"openalex":"https://openalex.org/W2275454249","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.7073","mag":"2275454249"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2004.22.14_suppl.7073","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.7073","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.7073","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083612799","display_name":"Harvey B. Niell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. B. Niell","raw_affiliation_strings":["University of Tennessee, Memphis, TN; University of North Carolina, Chapel Hill, NC; Hematology/Oncology Associates of Fayetteville, Fayetteville, NC; NE Oncology Associates, Concord, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Tennessee, Memphis, TN; University of North Carolina, Chapel Hill, NC; Hematology/Oncology Associates of Fayetteville, Fayetteville, NC; NE Oncology Associates, Concord, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078629724","display_name":"Mark A. Socinski","orcid":"https://orcid.org/0000-0003-2915-9325","observed_orcids":["https://orcid.org/0000-0003-2915-9325","https://orcid.org/0000-0002-8213-0137"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. A. Socinski","raw_affiliation_strings":["University of Tennessee, Memphis, TN; University of North Carolina, Chapel Hill, NC; Hematology/Oncology Associates of Fayetteville, Fayetteville, NC; NE Oncology Associates, Concord, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Tennessee, Memphis, TN; University of North Carolina, Chapel Hill, NC; Hematology/Oncology Associates of Fayetteville, Fayetteville, NC; NE Oncology Associates, Concord, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112495671","display_name":"K. Bakri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Bakri","raw_affiliation_strings":["University of Tennessee, Memphis, TN; University of North Carolina, Chapel Hill, NC; Hematology/Oncology Associates of Fayetteville, Fayetteville, NC; NE Oncology Associates, Concord, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Tennessee, Memphis, TN; University of North Carolina, Chapel Hill, NC; Hematology/Oncology Associates of Fayetteville, Fayetteville, NC; NE Oncology Associates, Concord, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Wall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Wall","raw_affiliation_strings":["University of Tennessee, Memphis, TN; University of North Carolina, Chapel Hill, NC; Hematology/Oncology Associates of Fayetteville, Fayetteville, NC; NE Oncology Associates, Concord, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Tennessee, Memphis, TN; University of North Carolina, Chapel Hill, NC; Hematology/Oncology Associates of Fayetteville, Fayetteville, NC; NE Oncology Associates, Concord, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062111389","display_name":"Maria Quintos Baggstrom","orcid":"https://orcid.org/0000-0002-8918-3565","observed_orcids":["https://orcid.org/0000-0002-8918-3565"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Baggstrom","raw_affiliation_strings":["University of Tennessee, Memphis, TN; University of North Carolina, Chapel Hill, NC; Hematology/Oncology Associates of Fayetteville, Fayetteville, NC; NE Oncology Associates, Concord, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Tennessee, Memphis, TN; University of North Carolina, Chapel Hill, NC; Hematology/Oncology Associates of Fayetteville, Fayetteville, NC; NE Oncology Associates, Concord, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110851716","display_name":"M. Pilar Escudero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Escudero","raw_affiliation_strings":["University of Tennessee, Memphis, TN; University of North Carolina, Chapel Hill, NC; Hematology/Oncology Associates of Fayetteville, Fayetteville, NC; NE Oncology Associates, Concord, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Tennessee, Memphis, TN; University of North Carolina, Chapel Hill, NC; Hematology/Oncology Associates of Fayetteville, Fayetteville, NC; NE Oncology Associates, Concord, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108612918","display_name":"Andrea Mears","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Mears","raw_affiliation_strings":["University of Tennessee, Memphis, TN; University of North Carolina, Chapel Hill, NC; Hematology/Oncology Associates of Fayetteville, Fayetteville, NC; NE Oncology Associates, Concord, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Tennessee, Memphis, TN; University of North Carolina, Chapel Hill, NC; Hematology/Oncology Associates of Fayetteville, Fayetteville, NC; NE Oncology Associates, Concord, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052952203","display_name":"Maureen T. Tynan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Tynan","raw_affiliation_strings":["University of Tennessee, Memphis, TN; University of North Carolina, Chapel Hill, NC; Hematology/Oncology Associates of Fayetteville, Fayetteville, NC; NE Oncology Associates, Concord, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Tennessee, Memphis, TN; University of North Carolina, Chapel Hill, NC; Hematology/Oncology Associates of Fayetteville, Fayetteville, NC; NE Oncology Associates, Concord, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":null,"display_name":"A. Ivanova","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Ivanova","raw_affiliation_strings":["University of Tennessee, Memphis, TN; University of North Carolina, Chapel Hill, NC; Hematology/Oncology Associates of Fayetteville, Fayetteville, NC; NE Oncology Associates, Concord, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Tennessee, Memphis, TN; University of North Carolina, Chapel Hill, NC; Hematology/Oncology Associates of Fayetteville, Fayetteville, NC; NE Oncology Associates, Concord, NC","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I114027177"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":"14_suppl","first_page":"7073","last_page":"7073"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.5776000022888184,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.5776000022888184,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.41819998621940613,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.890999972820282},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9940000176429749},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.968999981880188},{"id":"https://openalex.org/keywords/chemotherapy-schedule","display_name":"chemotherapy schedule","score":0.4699999988079071},{"id":"https://openalex.org/keywords/weekly-paclitaxel","display_name":"weekly paclitaxel","score":0.8460000157356262},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.6439999938011169},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.460999995470047},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.7889999747276306},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.781000018119812},{"id":"https://openalex.org/keywords/neuropathy","display_name":"neuropathy","score":0.8870000243186951},{"id":"https://openalex.org/keywords/myalgia","display_name":"myalgia","score":0.7250000238418579},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.9480000138282776},{"id":"https://openalex.org/keywords/advanced-non-small-cell-lung-cancer","display_name":"advanced non-small cell lung cancer","score":0.6209999918937683},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.3140000104904175},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.33799999952316284}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9326702356338501},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6443734765052795},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.540547788143158},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5075517892837524},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5072083473205566},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4639541506767273},{"id":"https://openalex.org/C2778616394","wikidata":"https://www.wikidata.org/wiki/Q474959","display_name":"myalgia","level":2,"score":0.4634632170200348},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.4372686743736267},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4299982190132141},{"id":"https://openalex.org/C2779177807","wikidata":"https://www.wikidata.org/wiki/Q3658562","display_name":"non-small cell lung cancer (NSCLC)","level":4,"score":0.4276798665523529},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2504119277000427},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.07706701755523682},{"id":"https://openalex.org/C81729549","wikidata":"https://www.wikidata.org/wiki/Q4649475","display_name":"A549 cell","level":3,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2004.22.14_suppl.7073","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.7073","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.7073","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"doi:10.1200/jco.2004.22.90140.7073","doi":"https://doi.org/10.1200/jco.2004.22.90140.7073","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.90140.7073","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2090528807","https://openalex.org/W2963741326","https://openalex.org/W2109063316","https://openalex.org/W2024480397","https://openalex.org/W2098126133","https://openalex.org/W1984641154","https://openalex.org/W2599287428","https://openalex.org/W2965642811","https://openalex.org/W2045193617","https://openalex.org/W2142042045"],"abstract_inverted_index":{"7073":[0],"Background:":[1],"C/P":[2,36,192,321],"remains":[3,18],"a":[4,22,28,124,288],"commonly":[5],"used":[6],"regimen":[7],"in":[8,37,330,357,366],"advanced":[9,367],"NSCLC":[10,47,368],"although":[11],"the":[12,38,97,174,205,313,331,344,347],"optimal":[13],"dose/schedule":[14],"of":[15,35,88,99,123,178,190,237,276,291,333,346,354],"both":[16,91,343],"agents":[17],"controversial.":[19],"We":[20],"designed":[21],"randomized":[23,49,130],"phase":[24],"II":[25],"trial":[26],"addressing":[27],"pure":[29],"schedule":[30,98,325,351],"question":[31],"over":[32],"4":[33,63,75,179],"cycles":[34,64,76,180],"first-line":[39],"setting.":[40],"Methods:":[41],"Patients":[42],"(pts)":[43],"with":[44,77,287,359],"stage":[45,153],"IIIB/IV":[46],"are":[48,93,170,200,213,242,256,269,340],"to":[50],"either":[51],"C":[52,68,360],"AUC":[53,69],"6":[54,70,112],"plus":[55],"P":[56,78,89],"225":[57],"mg/m2":[58],"every":[59,71],"3":[60,72],"weeks":[61,73,115],"for":[62,74,218,303],"(Arm":[65,83],"A)":[66],"or":[67,372,375],"75":[79],"mg/m2/wk":[80],"x":[81],"12":[82,114,188],"B).":[84,141],"Total":[85],"cumulative":[86],"doses":[87],"on":[90,117,184,193,224,232,246,258,263,323,342],"arms":[92,345],"identical":[94],"as":[95],"is":[96,105,281],"C.":[100],"The":[101,309],"FACT-L":[102,314],"QoL":[103,310],"instrument":[104],"being":[106],"performed":[107],"at":[108,111],"baseline":[109],"and":[110,113,187,244,249,261,271,297,306,337,352,364],"while":[116],"C/P.":[118],"Results:":[119],"Thus":[120],"far,":[121,133],"145":[122],"planned":[125],"160":[126],"pts":[127,278],"have":[128,181],"been":[129,182],"(Evaluable":[131],"thus":[132,279],"n=":[134,138],"67":[135],"Arm":[136,140,185,194,225,228,233,247,259,264],"A,":[137,234],"69":[139],"Patient":[142],"characteristics:":[143],"median":[144,177,289],"age":[145],"60":[146],"yrs":[147],"(range":[148],"38\u201385),":[149],"64%":[150],"male,":[151],"89%":[152],"IV:":[154],"11%":[155],"IIIB,":[156],"52%":[157],"KPS":[158,161],"70\u201380;":[159],"48%":[160],"90\u2013100%,":[162],"51%":[163],">":[164],"5%":[165],"wt":[166],"loss.":[167],"All":[168],"characteristics":[169],"well":[171],"balanced":[172],"between":[173,204],"arms.":[175,207],"A":[176,186,248,260,305],"delivered":[183],"wks":[189],"weekly":[191,355],"B.":[195],"Grade":[196,208],"3/4":[197],"hematologic":[198],"toxicities":[199,212],"not":[201,214],"significantly":[202,215],"different":[203,216],"two":[206],"\u2265":[209,238],"2":[210,240],"non-hematologic":[211,328],"except":[217],"myalgia/arthralgia":[219],"which":[220],"was":[221],"less":[222,327],"frequent":[223],"B":[226,229,265],"(4%":[227],"vs":[230],"18%":[231],"p=0.03).":[235],"Rates":[236],"grade":[239],"neuropathy":[241],"15%":[243],"12%":[245],"B,":[250,307],"respectively":[251],"(p=0.8).":[252],"Response":[253],"rates":[254,268],"(RR)":[255],"28%":[257],"35%":[262],"(stable":[266],"disease":[267],"39%":[270],"33%,":[272],"respectively).":[273],"Median":[274],"survival":[275,290,339],"all":[277],"far":[280],"8.3":[282],"months":[283,293,299],"(95%":[284,294,300],"CI,":[285,295,301],"6.4\u20139.0)":[286],"7.3":[292],"5.9\u20138.6)":[296],"8.7":[298],"6.5\u201310.4)":[302],"Arms":[304],"respectively.":[308],"information":[311],"from":[312],"will":[315],"be":[316],"presented.":[317],"Conclusions:":[318],"1)":[319],"Weekly":[320],"given":[322],"this":[324],"has":[326],"toxicity":[329],"form":[332],"myalgia/arthralgia,":[334],"2)":[335],"RR":[336],"overall":[338],"similar":[341],"trial,":[348],"3)":[349],"This":[350],"dose":[353],"paclitaxel":[356],"combination":[358],"every-3-wks":[361],"appears":[362],"active":[363],"well-tolerated":[365],"Author":[369],"Disclosure":[370],"Employment":[371],"Leadership":[373],"Consultant":[374],"Advisory":[376],"Stock":[377],"Ownership":[378],"Honoraria":[379],"Research":[380],"Funding":[381],"Expert":[382],"Testimony":[383],"Other":[384],"Remuneration":[385],"Bristol-Myers":[386,388],"Squibb":[387,389]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}